FLT4 and lymphedema: This situation may be expected in non-syndromic lymphedema, since only VEGFC/VEGFR3 axis genes that have been identified as the sole source of the disorder, yet 64% of patients with familial history and 92% of patients with sporadic non-syndromic lymphedema do not harbor these mutations [17], [42].